NCT02090530View on ClinicalTrials.gov

Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

November 4, 2013

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cancer
Interventions
OTHER

Biospecimen collection

Specimens to be collected include a fresh tumor biopsy, previously obtained tumor specimens or blocks (if available), whole blood, serum, plasma and buccal smear.

Trial Locations (1)

43210

RECRUITING

Ohio State University Wexner Medical Center, Columbus

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Ohio State University Comprehensive Cancer Center

OTHER